STO-CSCO Joint Symposium 2017

Continuing to build on the vibrant partnership of STO and CSCO, this symposium will be featured during the 20th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) from September 26 – 30, 2017.

Translated Articles

《肿瘤学家》精选论文
Read translations of selected articles targeting practice issues relevant to Chinese clinicians.

Browse All Topics

The Oncologist Clinical Trial Results

《肿瘤学家》中国项目概览
Download a 2-page pdf overview of The Oncologist’s Clinical Trial Results section information.

Video Library

视频库
Watch the latest presentations from the STO First Advisory Council: LUNG CANCER: A Grand Challenge for Public Health & Education.

Past Meetings

Welcome to 'The Oncologist' in China

Recent Translated Articles from The Oncologist

Volume 22, Number 7, July 2017


Clinical Trial Results

晚期肝细胞癌患者中Trebananib联合索拉非尼一线治疗的II期研究
Phase II Study of First‐Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa, Jean‐Frederic Blanc, Steven Miles, Tom Ganten, Jörg Trojan, Jonathan Cebon, Andre K. Liem, Lara Lipton, Charu Gupta, Benjamin Wu, Michael Bass, Ellen Hollywood, Jennifer Ma, Margaret Bradley, Jason Litten, Leonard B. Saltz
The Oncologist 2017; 22:780-e65; first published on June 7, 2017; doi:10.1634/theoncologist.2017-0058

在铂类药物预处理、晚期头颈部鳞状细胞癌中使用帕尼单抗的多中心II期研究
Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer
Marco Siano, Francesca Molinari, Vittoria Martin, Nicolas Mach, Martin Früh, Stefania Freguia, Irene Corradino, Michele Ghielmini, Milo Frattini, Vittoria Espeli
The Oncologist 2017; 22:782-e70; first published on June 7, 2017; doi:10.1634/theoncologist.2017-0069

一项依维莫司联合口服泼尼松治疗转移性肾细胞癌患者的II期研究
A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer
Cristian Lolli, Valentina Gallà, Giuseppe Schepisi, Domenico Barone, Salvatore Luca Burgio, Antonio Maugeri, Bernadette Vertogen, Dino Amadori, Ugo De Giorgi
The Oncologist 2017; 22:784-e74; first published on May 25, 2017; doi:10.1634/theoncologist.2017-0154

Academia-Pharma Intersect: Lung Cancer

BRAF突变型非小细胞肺癌的靶向治疗:从分子表达谱到合理设计治疗
Targeting BRAF‐Mutant Non‐Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy
Christina S. Baik, Nathaniel J. Myall, Heather A. Wakelee
The Oncologist 2017; 22:786-796; first published on May 9, 2017; doi:10.1634/theoncologist.2016-0458

Gastrointestinal Cancer

BRCA相关性胆管癌的总生存期和临床特征:一项多中心回顾性研究
Overall Survival and Clinical Characteristics of BRCA‐Associated Cholangiocarcinoma: A Multicenter Retrospective Study
Talia Golan, Maria Raitses‐Gurevich, Robin K. Kelley, Andrea G. Bocobo, Ayelet Borgida, Rachna T. Shroff, Spring Holter, Steven Gallinger, Daniel H. Ahn, Dan Aderka, Jain Apurva, Tanois Bekaii‐Saab, Eitan Friedman, Milind Javle
The Oncologist 2017; 22:804-810; first published on May 9, 2017; doi:10.1634/theoncologist.2016-0415

Symptom Management and Supportive Care

台湾当局关于推行癌症患者临终关怀的政策:加大临终关怀的资源利用并降低临终诊治的侵入性
National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End‐of‐Life Care for Cancer Patients
Yu‐Yun Shao, Emily Han‐Chung Hsiue, Chih‐Hung Hsu, Chien‐An Yao, Ho‐Min Chen, Mei‐Shu Lai, Ann‐Lii Cheng
The Oncologist 2017; 22:843-849; first published on April 13, 2017; doi:10.1634/theoncologist.2016-0367

No front page content has been created yet.

 

The Oncologist and the Society for Translational Oncology (STO) partner with the Chinese Society of Clinical Oncology (中国抗癌协会临床肿瘤学协作专业委员会, CSCO) and the CSCO Foundation (中国临床肿瘤学会基金会) on educational initiatives that address critical health and cancer care issues in China. These efforts serve to foster communication between Chinese physicians and other leaders in oncology practice throughout the world.